NCT00037804View on ClinicalTrials.gov

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Unspecified Adult Solid TumorChemotherapyLiver DysfunctionNeoplasms, Solid Tumor
Interventions
DRUG

Irinotecan

Trial Locations (4)

37232

Research Center, Nashville

48201

Research Center, Detroit

54449

Research Center, Marshfield

08901

Research Center, New Brunswick

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00037804 - Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | Biotech Hunter | Biotech Hunter